Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Validation of the Scored Patient-Generated Subjective Global Assessment (PG-SGA) in Thai Setting and Association with Nutritional Parameters in Cancer Patients

Nitichai N, Angkatavanich J, Somlaw N, Voravud N, Lertbutsayanukul C.

Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1249-1255.

2.

Effects of CYP2D6 and UGT2B7 polymorphisms on pharmacokinetics of tamoxifen in Thai breast cancer patients.

Areepium N, Panomvana D, Rungwanonchai P, Sathaporn S, Voravud N.

Breast Cancer (Dove Med Press). 2013 Aug 22;5:73-8. doi: 10.2147/BCTT.S47172. eCollection 2013.

3.

Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia.

Chalermchai T, Tantiphlachiva K, Suwanrusme H, Voravud N, Sriuranpong V.

Asia Pac J Clin Oncol. 2010 Sep;6(3):155-60. doi: 10.1111/j.1743-7563.2010.01311.x.

PMID:
20887495
4.

Retrospective review of extra-pulmonary small cell carcinoma at King Chulalongkorn memorial hospital cases during 1998-2005.

Chalermchai T, Suwanrusme H, Chantranuwat P, Voravud N, Sriuranpong V.

Asia Pac J Clin Oncol. 2010 Jun;6(2):111-5. doi: 10.1111/j.1743-7563.2010.01284.x.

PMID:
20565423
5.

Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009.

Wong NS, Anderson BO, Khoo KS, Ang PT, Yip CH, Lu YS, Voravud N, Shao ZM, Pritchard KI; Asian Oncology Summit.

Lancet Oncol. 2009 Nov;10(11):1077-85. doi: 10.1016/S1470-2045(09)70230-X. Review.

PMID:
19880061
6.

Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.

Voravud N, Sriuranpong V, Suwanrusme H.

J Med Assoc Thai. 2007 Jun;90(6):1082-8.

PMID:
17624200
7.

Histopathologic characteristics of pulmonary adenocarcinomas with and without EGFR mutation.

Chantranuwat C, Sriuranpong V, Huapai N, Chalermchai T, Leungtaweeboon K, Voravud N, Mutirangura A.

J Med Assoc Thai. 2005 Sep;88 Suppl 4:S322-9.

PMID:
16623049
8.

Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.

Voravud N, Sriuranpong V.

J Med Assoc Thai. 2005 Dec;88(12):1790-6.

PMID:
16518975
9.

High frequency of mutation of epidermal growth factor receptor in lung adenocarcinoma in Thailand.

Sriuranpong V, Chantranuwat C, Huapai N, Chalermchai T, Leungtaweeboon K, Lertsanguansinchai P, Voravud N, Mutirangura A.

Cancer Lett. 2006 Aug 8;239(2):292-7. Epub 2005 Oct 21.

PMID:
16243431
11.

Pattern of local-regional recurrence in patient with early breast cancer after mastectomy: an analysis of 357 cases at King Chulalongkorn Memorial Hospital.

Lertsanguansinchai P, Lertbutsayanukul C, Chatamra K, Shotelersuk K, Voravud N, Khorprasert C.

J Med Assoc Thai. 2004 Sep;87 Suppl 2:S168-74.

PMID:
16083182
12.

Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis.

Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, Thong-ngam D, Voravud N, Sriuranpong V, Mutirangura A.

Oncogene. 2004 Nov 18;23(54):8841-6.

PMID:
15480421
13.

Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays.

Sriuranpong V, Mutirangura A, Gillespie JW, Patel V, Amornphimoltham P, Molinolo AA, Kerekhanjanarong V, Supanakorn S, Supiyaphun P, Rangdaeng S, Voravud N, Gutkind JS.

Clin Cancer Res. 2004 Aug 1;10(15):4944-58.

14.

Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer.

Hirunsatit R, Kongruttanachok N, Shotelersuk K, Supiyaphun P, Voravud N, Sakuntabhai A, Mutirangura A.

BMC Genet. 2003 Jan 21;4:3. Epub 2003 Jan 21.

15.

Clinical significance of p53 antigen and anti-p53 antibodies in the sera of hepatocellular carcinoma patients.

Charuruks N, Tangkijvanich P, Voravud N, Chatsantikul R, Theamboonlers A, Poovorawan Y.

J Gastroenterol. 2001 Dec;36(12):830-6.

PMID:
11777211
17.

Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study.

Kongruttanachok N, Sukdikul S, Setavarin S, Kerekhjanarong V, Supiyaphun P, Voravud N, Poovorawan Y, Mutirangura A.

BMC Cancer. 2001;1:4. Epub 2001 May 25.

18.

Human papillomavirus DNA in plasma of patients with cervical cancer.

Pornthanakasem W, Shotelersuk K, Termrungruanglert W, Voravud N, Niruthisard S, Mutirangura A.

BMC Cancer. 2001;1:2. Epub 2001 Mar 5.

19.

Erythropoietin level and hematologic parameters in healthy adults.

Charuruks N, Limpanasithikul W, Voravud N, Sutheesophon K.

J Med Assoc Thai. 2000 Oct;83(10):1267-73.

PMID:
11143495
20.

Telomerase assay and nested polymerase chain reaction from nasopharyngeal swabs for early noninvasive detection of nasopharyngeal carcinoma.

Kerekhanjanarong V, Sitawarin S, Sakdikul S, Saengpanich S, Chindavijak S, Supiyaphun P, Voravud N, Mutirangura A.

Otolaryngol Head Neck Surg. 2000 Nov;123(5):624-9.

PMID:
11077353
21.

Outcomes of primary hepatocellular carcinoma treatment: an 8-year experience with 368 patients in Thailand.

Pawarode A, Tangkijvanich P, Voravud N.

J Gastroenterol Hepatol. 2000 Aug;15(8):860-4.

PMID:
11022825
22.

Phase II trial of tropisetron and dexamethasone in the prevention of cisplatin-induced emesis.

Voravud N, Suwanrusmee H.

J Med Assoc Thai. 2000 Jun;83(6):668-75.

PMID:
10932495
23.

Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer.

Shotelersuk K, Khorprasert C, Sakdikul S, Pornthanakasem W, Voravud N, Mutirangura A.

Clin Cancer Res. 2000 Mar;6(3):1046-51.

24.

Recombinant interferon-alpha 2b and megestrol acetate in patients with advanced renal cell carcinoma.

Voravud N, Sriuranpong V, Lertsaguansinchai P.

J Med Assoc Thai. 2000 Feb;83(2):123-8.

PMID:
10710880
25.

Telomerase assay for differentiating between malignancy-related and nonmalignant ascites.

Tangkijvanich P, Tresukosol D, Sampatanukul P, Sakdikul S, Voravud N, Mahachai V, Mutirangura A.

Clin Cancer Res. 1999 Sep;5(9):2470-5.

26.

Identification of distinct regions of allelic loss on chromosome 13q in nasopharyngeal cancer from paraffin embedded tissues.

Mutirangura A, Charuruks N, Shuangshoti S, Sakdikul S, Chatsantikul R, Pornthanakasem W, Sriuranpong V, Supiyaphun P, Voravud N.

Int J Cancer. 1999 Oct 8;83(2):210-4.

27.

P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis.

Charuruks N, Shin DM, Voravud N, Ro JY, Hong WK, Hittelman WN.

J Med Assoc Thai. 1999 May;82(5):466-76.

PMID:
10443096
28.

Tumor angiogenesis.

Voravud N, Charuruk N.

J Med Assoc Thai. 1999 Apr;82(4):394-404. Review.

PMID:
10410503
29.

13-cis-retinoic acid and interferon-alpha 2a therapy in locally advanced squamous cell carcinoma of the cervix: p53 alteration, proliferating cell nuclear antigen expression and angiogenesis response.

Charuruks N, Voravud N, Termrungruanglert W, Lertsanguansinchai P, Tresukosol D, Niruthisard S, Sirisabya N.

J Obstet Gynaecol Res. 1998 Oct;24(5):335-41.

PMID:
9879152
30.

Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions.

Mutirangura A, Sriuranpong V, Termrunggraunglert W, Tresukosol D, Lertsaguansinchai P, Voravud N, Niruthisard S.

Br J Cancer. 1998 Oct;78(7):933-9.

31.

Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma.

Mutirangura A, Pornthanakasem W, Sriuranpong V, Supiyaphun P, Voravud N.

Int J Cancer. 1998 Oct 5;78(2):153-6.

32.

Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients.

Pawarode A, Voravud N, Sriuranpong V, Kullavanijaya P, Patt YZ.

Am J Clin Oncol. 1998 Aug;21(4):386-91.

PMID:
9708639
33.

Reference ranges of reticulocytes in adults.

Charuruks N, Limpanasithikul W, Voravud N, Virochpoka T, Nuchprayoon C.

J Med Assoc Thai. 1998 May;81(5):357-64.

PMID:
9623036
34.

Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.

Mutirangura A, Pornthanakasem W, Theamboonlers A, Sriuranpong V, Lertsanguansinchi P, Yenrudi S, Voravud N, Supiyaphun P, Poovorawan Y.

Clin Cancer Res. 1998 Mar;4(3):665-9.

35.
36.
37.

Squamous cell carcinoma of head and neck.

Voravud N, Charuruks N, Mutirangura A.

J Med Assoc Thai. 1997 Apr;80(4):207-18. Review.

PMID:
9175390
38.

Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection.

Mutirangura A, Tanunyutthawongese C, Pornthanakasem W, Kerekhanjanarong V, Sriuranpong V, Yenrudi S, Supiyaphun P, Voravud N.

Br J Cancer. 1997;76(6):770-6.

39.
40.

Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.

Charuruks N, Shin DM, Voravud N, Ro JY, Hong WK, Hittelman WN.

J Med Assoc Thai. 1996 Dec;79 Suppl 1:S104-12.

PMID:
9071074
41.

Microsatellite instability in Epstein-Barr virus associated with nasopharyngeal carcinoma.

Tanunyutthawongese C, Sriuranpong V, Kerekhanjanarong V, Changchup B, Yenrudi S, Supiyaphun P, Voravud N, Mutirangura A.

J Med Assoc Thai. 1996 Dec;79 Suppl 1:S71-7.

PMID:
9071070
42.

Loss of heterozygosity for chromosome 11 in Epstein-Barr-virus associated nasopharyngeal carcinoma.

Mutirangura A, Tanunyutthawongese C, Kerekhanjanarong V, Sriuranpong V, Pornthanakasem W, Yenrudi S, Supiyaphun P, Voravud N.

J Med Assoc Thai. 1996 Dec;79 Suppl 1:S65-70.

PMID:
9071069
43.

Genetic instability and the development of recurrence of primary tumor and second primary tumor during head and neck tumorigenesis.

Charuruks N, Shin DM, Voravud N, Ro JY, Hong WK, Hittelman WN.

J Med Assoc Thai. 1996 Dec;79 Suppl 1:S49-55.

PMID:
9071067
44.

Molecular biology of head and neck tumorigenesis: the role of p53 expression and genetic instability.

Charuruks N, Voravud N.

J Med Assoc Thai. 1996 Dec;79 Suppl 1:S3-10. Review.

PMID:
9071061
45.

Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma.

Mutirangura A, Supiyaphun P, Trirekapan S, Sriuranpong V, Sakuntabhai A, Yenrudi S, Voravud N.

Cancer Res. 1996 Aug 1;56(15):3530-3.

46.

In situ hybridization: a new tool in molecular medicine.

Charuruks N, Voravud N.

J Med Assoc Thai. 1996 Jun;79(6):374-81. Review.

PMID:
8855612
47.

Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.

Poshyachinda M, Chaiwatanarat T, Saesow N, Thitathan S, Voravud N.

Eur J Nucl Med. 1996 Jun;23(6):624-30.

PMID:
8662095
48.

Chemoprevention of head and neck cancer.

Voravud N.

J Med Assoc Thai. 1996 Mar;79(3):185-93. Review.

PMID:
8708501
49.

Antineoplastic-associated colitis in Chulalongkorn University Hospital.

Sriuranpong V, Voravud N.

J Med Assoc Thai. 1995 Aug;78(8):424-30.

PMID:
7561566
50.

CA 50: a tumor marker for gastrointestinal malignancies.

Bunworasate U, Voravud N.

J Med Assoc Thai. 1995 May;78(5):255-70. Review.

PMID:
7561549

Supplemental Content

Loading ...
Support Center